{
  "docId": "019dd923-5ca1-7489-b636-bc879d1b6d64",
  "docSlug": "17680cec2cbd3510",
  "documentTitle": "Accelerated Access Review UK Mapping",
  "authorId": "Deloitte",
  "authorName": "Deloitte",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.333,
  "pageNumber": 13,
  "pageCount": 109,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "situation_overview",
  "function": "establish_context",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": [
    "headline_text",
    "paragraph",
    "numbered_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b636-bc879d1b6d64/13",
  "deckHref": "/decks/019dd923-5ca1-7489-b636-bc879d1b6d64",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b636-bc879d1b6d64.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b636-bc879d1b6d64#slide-13",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "The objective of workstream 1 is to assess the As-Is environment in the UK and the barriers to getting patients earlier access to medical innovation.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-ba8c-7422-853a-e68dd044fb73",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.8,
        "x": 0.07,
        "y": 0.57
      },
      "kind": "list",
      "text": "Identify key priorities for action\nProvide implementable suggestions for change to accelerate innovation access\nDevelop a sustainable framework to support and drive medical innovation\nConsider the long term landscape for innovation adoption",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "eaf737e5-cc3c-4f8c-ad1b-5a3b212f2e47",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.92,
        "x": 0.04,
        "y": 0.43
      },
      "kind": "paragraph",
      "text": "With initial findings being reported in late Summer, the work will identify key challenges across the end-to-end pathway and provide opportunities for change to accelerate patient access of upcoming innovative medicine and medtech in the current pathways. Specifically the review will achieve the following outcomes:",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3969778b-53b9-45c8-8e2a-673d5102d0ce",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.92,
        "x": 0.04,
        "y": 0.79
      },
      "kind": "paragraph",
      "text": "There are a number of workstreams contributing to the review and this report focuses on Workstream 1. The objective of workstream 1 is to assess the As-Is environment in the UK and the barriers to getting patients earlier access to medical innovation.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "682bfe0d-1e96-4b22-8957-889750083d27",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.92,
        "x": 0.04,
        "y": 0.13
      },
      "kind": "paragraph",
      "text": "The review will make recommendations to government on opportunities to accelerate access for NHS patients to innovate medicines and medtech",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "da446cbd-cfab-465e-9449-7cfa6121723b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.92,
        "x": 0.04,
        "y": 0.25
      },
      "kind": "paragraph",
      "text": "The Accelerated Access – Innovative Medicines and Medical Technologies Review (IMMTR) announced by George Freeman on 20th November 2014 will consider how the healthcare and regulatory systems can best respond and adapt to the new landscape of digital diagnostics, genomics and precision medicine. The review will consider how to speed up access for NHS patients to cost-effective new diagnostics, medicines and devices.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f458296f-b2ba-43d7-8304-c5f26638caa5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.45,
        "x": 0.04,
        "y": 0.04
      },
      "kind": "title",
      "text": "Accelerated Access Review",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "650603be-9862-45a1-b457-434d6fb58ee8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "e0e8271f-d748-4baf-84e0-3a1c8dbb2747",
      "evidence": "The review will make recommendations to government on opportunities to accelerate access for NHS patients to innovate medicines and medtech",
      "confidence": 0.7
    },
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "2de514aa-7670-4934-aec6-1d4c8e26a9be",
      "evidence": "The Accelerated Access – Innovative Medicines and Medical Technologies Review (IMMTR) announced by George Freeman on 20th November 2014 will consider how the healthcare and regulatory systems can bes",
      "confidence": 0.6
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 20,
      "from": 10,
      "beatId": "aacd1ccc-bd28-4624-b7f6-626b3a9a4a01",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Agitate (Make it worse)",
      "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
      "evidence": "The document highlights the consequences of not addressing these challenges, such as limited access to new treatments and technologies.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [
    {
      "to": 20,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "216c31e8-2aee-4a6b-81ea-25d4d04ac422",
      "evidence": "The document highlights the consequences of not addressing the challenges, such as limited access to new treatments and technologies.",
      "position": 0,
      "objective": "What are the consequences of not improving access to medical innovations?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}